Medical Tubing and Extrusion

Medical tubing and extrusion technologies

Ancora Heart, Egnite partner on AccuCinch trial enrollment

By

Ancora-Heart-logoAncora Heart announced that it entered into a strategic partnership with Egnite to accelerate clinical trial enrollment.

The partnership centers around the Ancora Heart CORCINCH-HF pivotal clinical trial. It evaluates the safety and efficacy of the AccuCinch ventricular restoration system. Together, the companies aim to combine cutting-edge technology and expertise to deliver therapies to patients faster.

Egnite’s artificial intelligence (AI)-based Trial Accelerator technology helps to identify eligible patients for the trial. The Christ Health Network in Cincinnati, Ohio, first utilized the technology in CORCINCH-HF.

Get the full story on our sister site, MassDevice.

About Danielle Kirsh

Danielle Kirsh is an award-winning journalist and senior editor for Medical Tubing + Extrusion, Medical Design & Outsourcing and MassDevice. She received her bachelor's degree in broadcast journalism and mass communication from Norfolk State University and is pursuing her master's in global strategic communications at the University of Florida. You can connect with her on Twitter and LinkedIn, or email her at dkirsh@wtwhmedia.com.